Stock Research: Carl Zeiss Meditec

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Carl Zeiss Meditec

XTRA:AFX DE0005313704
51
  • Value
    69
  • Growth
    27
  • Safety
    Safety
    82
  • Combined
    88
  • Sentiment
    18
  • 360° View
    360° View
    51
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Carl Zeiss Meditec AG is a medical technology and device company offering solutions for diagnosing and treating ophthalmic diseases. It operates in the medical technology industry, specifically in ophthalmic devices and microsurgery. The company operates in Germany and offers support services. In the last fiscal year, the company had a market cap of $5,249 million, profits of $1,212 million, and revenue of $2,300 million, with 5,730 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 51 (better than 51% compared with alternatives), overall professional sentiment and financial characteristics for the stock Carl Zeiss Meditec are above average. The 360° View is based on consolidating four consolidated indicators, with half the metrics below and half above average for Carl Zeiss Meditec. The consolidated Value Rank has an attractive rank of 82, which means that the share price of Carl Zeiss Meditec is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 82% of alternative stocks in the same industry. The company is also safely financed with a Safety rank of 69. But the professional market sentiment is below average compared with other stock investment alternatives with a Sentiment Rank of 18. Professional investors are more confident in 82% other stocks. The consolidated Growth Rank also has a low rank of 27, which means that the company is below average in terms of growth momentum when looking at financial metrics such as revenue, profit, invested capital growth, and stock returns. 73 of its competitors have better growth. ...read more

more
Index
CDAX
Energy Efficient
Low Waste
Renewables Users
Sound Pay Europe
MDAX
TecDAX
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
82 72 43 31
Growth
27 12 53 57
Safety
Safety
69 79 86 90
Sentiment
18 1 3 70
360° View
360° View
51 22 45 81
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
37 19 12 19
Opinions Change
19 15 10 56
Pro Holdings
n/a 8 26 86
Market Pulse
56 25 38 62
Sentiment
18 1 3 70
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
82 72 43 31
Growth
27 12 53 57
Safety Safety
69 79 86 90
Combined
88 64 82 71
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
64 39 32 19
Price vs. Earnings (P/E)
71 61 42 22
Price vs. Book (P/B)
75 70 29 36
Dividend Yield
63 54 55 45
Value
82 72 43 31
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
44 57 63 45
Profit Growth
14 8 26 17
Capital Growth
85 66 81 81
Stock Returns
17 4 31 67
Growth
27 12 53 57
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
68 62 80 82
Refinancing
65 63 63 53
Liquidity
42 55 67 77
Safety Safety
69 79 86 90

Similar Stocks

Discover high‑ranked alternatives to Carl Zeiss Meditec and broaden your portfolio horizons.

thyssenkrupp

XTRA:TKA
Country: Germany
Industry: Steel
Size: X-Large
Full Stock Analysis

KSB

XTRA:KSB
Country: Germany
Industry: Industrial Machinery
Size: Medium
Full Stock Analysis

Infineon

XTRA:IFX
Country: Germany
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

Indus

XTRA:INH
Country: Germany
Industry: Industrial Conglomerates
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.